Search Results - "Cymberknoh, M. Cohen"

Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis by WILSCHANSKI, M, MILLER, L. L, COHEN-CYMBERKNOH, M, MILLER, N. L, REHA, A, NORTHCUTT, V. J, HIRAWAT, S, DONNELLY, K, ELFRING, G. L, AJAYI, T, KEREM, E, SHOSEYOV, D, BLAU, H, RIVLIN, J, AVIRAM, M, COHEN, M, ARMONI, S, YAAKOV, Y, PUGATCH, T

“…In a subset of patients with cystic fibrosis (CF), nonsense mutations (premature stop codons) disrupt production of full-length, functional CF transmembrane…”
Get full text

The Long-Term Effect of a Quality Improvement Intervention in the Management of Bronchiolitis by Reiter, J., Berkovits, A., Breuer, A., Hashavya, S., Rekhtman, D., Cohen-Cymberknoh, M.

“…Quality improvement interventions have been shown to improve adherence with bronchiolitis treatment guidelines; however, the long-term effect of these…”
Get full text

What's new in the diagnosis of CF? by Cohen-Cymberknoh, M

Get full text

Fungal infection and ABPA in CF by Cohen-Cymberknoh, M

Get full text

26 Nasal potential difference in young children is feasible by Cohen, M, Yaakov, Y, Friedman, H, Shoseyov, D, Cohen-Cymberknoh, M, Kerem, E, Wilschanski, M

Get full text

67 Effect Size: a quantitative method for the evaluation of treatment effect in n=1 studies by Israeli, T, Eisenstadt, I, Cohen-Cymberknoh, M, Reiter, J, Armoni, S, Elyashar-Earon, H, Tsabari, R, Gileles-Hillel, A, Shoseyov, D, Kerem, E, Breuer, O

Get full text

EPS2.6 Prevalence and characteristics of attention deficit hyperactivity disorder in patients with cystic fibrosis by Tanny, T, Breuer, O, Blau, H, Kadosh, D, Mussaffi, H, Gartner, S, Salinas, A, Bentur, L, Nir, V, Gur, M, Shoseyov, D, Kerem, E, Berger, I, Cohen-Cymberknoh, M

Get full text

WS20.3 Acquired CFTR dysfunction in patients with primary ciliary dyskinesia (PCD)? by Cohen-Cymberknoh, M, Bar, G, Yaakov, Y, Cohen, M, Shoseyov, D, Kerem, E, Wilschanski, M

“…It has been shown that chronic bronchitis, cigarette smoke, hypoxia, and chronic airways inflammation are associated with reduced CFTR function. Primary…”
Get full text

WS04.5 Vitamin D influence on respiratory exacerbations and hospitalizations in cystic fibrosis patients by Abu-Fraiha, Y, Elyashar-Earon, H, Shoseyov, D, Cohen-Cymberknoh, M, Armoni, S, Kerem, E, Wilschanski, M

“…Objectives Cystic Fibrosis (CF) is highly associated with vitamin D deficiency. In April 2012, a guidelines-committee of The CF Foundation published new…”
Get full text

222 Successful administration of continuous intravenous β-lactam therapy for allergic CF patients failing standard antibiotic desensitization by Breuer, O, Cohen-Cymberknoh, M, Armoni, S, Kerem, E, Shoseyov, D

Get full text

WS16.5 Website based educational program on cystic fibrosis (CF) for community physicians by Pugatsch, T, Cohen-Cymberknoh, M, Elyashar-Earon, H, Eisenstadt, I, Wilschanski, M, Breuer, O, Kurz, S, Palmor, S, Armoni, S, Kerem, E

Get full text

223 Infertility among women with cystic fibrosis: prevalence and risk factors by Shteinberg, M, Lulu, A. Ben, Blumenfeld, Z, Gur, M, Bentur, L, Mussaffi, H, Blau, H, Sarouk, I, Efrati, O, Cohen-Cymberknoh, M, Kerem, E, Aviram, M, Pickard, E, Livnat, G

Get full text

300 Prevalence and characteristics of attention deficit hyperactivity disorder (ADHD) in patients with cystic fibrosis (CF) by Cohen-Cymberknoh, M, Tanny, T, Blau, H, Kadosh, D, Mussaffi, H, Nir, V, Bentur, L, Shoseyov, D, Kerem, E, Berger, I

“…Patients with Cystic fibrosis (CF) need daily treatments to control the disease, which requires time, energy, and persistence. One possible barrier to…”
Get full text

ePS06.7 Factors associated with failure to eradicate first or newly acquired Pseudomonas aeruginosa in patients with CF by Cohen-Cymberknoh, M, Gilead, N, Gartner, S, Simanovski, N, Canino, E, Carreño, J.C, Blau, H, Mussaffi, H, Gur, M, Rivlin, J, Bentur, L, Aviram, M, Picard, E, Hiller, N, Armoni, S, Breuer, O, Shoseyov, D, Kerem, E

“…Respiratory infections with P. aeruginosa (PA) are a leading cause of morbidity-mortality in Cystic fibrosis (CF) patients. Several protocols for eradication…”
Get full text

147 Causes of failure to eradicate Pseudomonas aeruginosa in patients with CF by Cohen-Cymberknoh, M, Gilead, N, Shoseyov, D, Breuer, O, Blau, H, Muzzafi, H, Gur, M, Rivlin, J, Picard, E, Armoni, S, Aviram, M, Bentur, L, Kerem, E

Get full text

297 Arab cystic fibrosis patients in Israel by Lavie, M, Lifshitz, I, Vilozni, D, Shapira, I, Sarouk, I, Bar, B.-E, Dagan, A, Livnat, G, Cohen-Cymberknoh, M, Mei-Zahav, M, Rivlin, J, Efrati, O

Get full text

Clinical presentation, course and outcome of community acquired complicated pneumonia in Jerusalem 2000–2010 by Erlichman, I, Cohen-Cymberknoh, M, Shoseyo, D, Koplewit, B, Fisher, D, Picard, E, Erlichman, M, Kerem, E

Get full text

Comparison of disease expression between patients with primary ciliary dyskinesia (PCD) and patients with CF and pancreatic sufficiency (CF-PS) and insufficiency (CF-PI) by Cohen-Cymberknoh, M, Simanovski, N, Hiller, N, Hillel, A. Gilleles, Shoseyov, D, Kerem, E

Get full text

Building a CF Center in Gaza – a bridge over troubled water by Kerem, E, Shoseyov, D, Cohen-Cymberknoh, M, Armoni, S, Shanit, D

Get full text

Propranolol in the treatment of subglottic hemangioma by Cohen-Cymberknoh, M, Avital, A, Shoseyov, D, Hevroni, A, Kerem, E, Springer, C

Get full text